Intraoperative characteristics and postoperative outcomes before and after matching
| . | Before matching . | After matching . | ||||
|---|---|---|---|---|---|---|
| Vascular complications (n = 284) . | No vascular complications (n = 1,877) . | P-Value . | Vascular complications (n = 270) . | No vascular complications (n = 727) . | P-Value . | |
| Operative time (min), median (IQR) | 68.0 (45.0; 86.2) | 48.0 (45.0; 60.0) | <0.001 | 63.5 (45.0; 80.0) | 50.0 (45.0; 60.0) | <0.001 |
| Need for vascular surgery, n (%) | 30 (10.7) | 0 (0.00) | <0.001 | 26 (9.74) | 0 (0.00) | <0.001 |
| Conversion to sternotomy, n (%) | 4 (1.41) | 6 (0.32) | 0.032 | 3 (1.11) | 2 (0.28) | 0.126 |
| Need for endovascular treatment,a n (%) | 230 (81.9) | 0 (0.00) | <0.001 | 224 (83.6) | 0 (0.00) | <0.001 |
| Number of implanted stents, n (%) | <0.001 | <0.001 | ||||
| 1 | 195 (69.6) | 0 (0.00) | 189 (70.8) | 0 (0.00) | ||
| 2 | 25 (8.93) | 0 (0.00) | 25 (9.36) | 0 (0.00) | ||
| 3 | 4 (1.43) | 0 (0.00) | 4 (1.50) | 0 (0.00) | ||
| 4 | 3 (1.07) | 0 (0.00) | 3 (1.12) | 0 (0.00) | ||
| Operative mortality, n (%) | 8 (2.82) | 9 (0.48) | 0.001 | 7 (2.59) | 5 (0.69) | 0.022 |
| In-hospital mortality, n (%) | 18 (6.34) | 39 (2.08) | <0.001 | 17 (6.30) | 23 (3.16) | 0.040 |
| Hospital length of stay (days), median (IQR) | 8.00 (6.00; 13.0) | 7.00 (5.00; 10.0) | <0.001 | 8.00 (5.75; 13.0) | 7.00 (5.00; 10.0) | 0.001 |
| Complications, n (%) | ||||||
| Conduction disorders, including pacemaker | 58 (20.4) | 432 (23.0) | 0.370 | 56 (20.7) | 151 (20.8) | 1.000 |
| Pacemaker implantation | 57 (20.1) | 376 (20.0) | 1.000 | 55 (20.4) | 130 (17.9) | 0.420 |
| ICD implantation | 0 (0.00) | 8 (0.43) | 0.607 | 0 (0.00) | 1 (0.14) | 1.000 |
| Valve-related complications | 2 (0.70) | 21 (1.12) | 0.759 | 2 (0.74) | 9 (1.24) | 0.737 |
| Stroke | 9 (3.17) | 31 (1.65) | 0.126 | 8 (2.96) | 14 (1.93) | 0.454 |
| Blood transfusion | 63 (22.2) | 59 (3.14) | <0.001 | 55 (20.4) | 31 (4.26) | <0.001 |
| Infectious complications | 26 (9.15) | 58 (3.09) | <0.001 | 24 (8.89) | 28 (3.85) | 0.003 |
| Dialysis | 94 (37.0) | 473 (28.3) | 0.005 | 90 (37.5) | 199 (31.2) | 0.093 |
| . | Before matching . | After matching . | ||||
|---|---|---|---|---|---|---|
| Vascular complications (n = 284) . | No vascular complications (n = 1,877) . | P-Value . | Vascular complications (n = 270) . | No vascular complications (n = 727) . | P-Value . | |
| Operative time (min), median (IQR) | 68.0 (45.0; 86.2) | 48.0 (45.0; 60.0) | <0.001 | 63.5 (45.0; 80.0) | 50.0 (45.0; 60.0) | <0.001 |
| Need for vascular surgery, n (%) | 30 (10.7) | 0 (0.00) | <0.001 | 26 (9.74) | 0 (0.00) | <0.001 |
| Conversion to sternotomy, n (%) | 4 (1.41) | 6 (0.32) | 0.032 | 3 (1.11) | 2 (0.28) | 0.126 |
| Need for endovascular treatment,a n (%) | 230 (81.9) | 0 (0.00) | <0.001 | 224 (83.6) | 0 (0.00) | <0.001 |
| Number of implanted stents, n (%) | <0.001 | <0.001 | ||||
| 1 | 195 (69.6) | 0 (0.00) | 189 (70.8) | 0 (0.00) | ||
| 2 | 25 (8.93) | 0 (0.00) | 25 (9.36) | 0 (0.00) | ||
| 3 | 4 (1.43) | 0 (0.00) | 4 (1.50) | 0 (0.00) | ||
| 4 | 3 (1.07) | 0 (0.00) | 3 (1.12) | 0 (0.00) | ||
| Operative mortality, n (%) | 8 (2.82) | 9 (0.48) | 0.001 | 7 (2.59) | 5 (0.69) | 0.022 |
| In-hospital mortality, n (%) | 18 (6.34) | 39 (2.08) | <0.001 | 17 (6.30) | 23 (3.16) | 0.040 |
| Hospital length of stay (days), median (IQR) | 8.00 (6.00; 13.0) | 7.00 (5.00; 10.0) | <0.001 | 8.00 (5.75; 13.0) | 7.00 (5.00; 10.0) | 0.001 |
| Complications, n (%) | ||||||
| Conduction disorders, including pacemaker | 58 (20.4) | 432 (23.0) | 0.370 | 56 (20.7) | 151 (20.8) | 1.000 |
| Pacemaker implantation | 57 (20.1) | 376 (20.0) | 1.000 | 55 (20.4) | 130 (17.9) | 0.420 |
| ICD implantation | 0 (0.00) | 8 (0.43) | 0.607 | 0 (0.00) | 1 (0.14) | 1.000 |
| Valve-related complications | 2 (0.70) | 21 (1.12) | 0.759 | 2 (0.74) | 9 (1.24) | 0.737 |
| Stroke | 9 (3.17) | 31 (1.65) | 0.126 | 8 (2.96) | 14 (1.93) | 0.454 |
| Blood transfusion | 63 (22.2) | 59 (3.14) | <0.001 | 55 (20.4) | 31 (4.26) | <0.001 |
| Infectious complications | 26 (9.15) | 58 (3.09) | <0.001 | 24 (8.89) | 28 (3.85) | 0.003 |
| Dialysis | 94 (37.0) | 473 (28.3) | 0.005 | 90 (37.5) | 199 (31.2) | 0.093 |
Infectious complications include septic shock, local access site infections and pulmonary infections.
Stent implantation/balloon dilatation/Fogarty.
ICD: implantable cardioverter–defibrillator; IQR: interquartile range.
Intraoperative characteristics and postoperative outcomes before and after matching
| . | Before matching . | After matching . | ||||
|---|---|---|---|---|---|---|
| Vascular complications (n = 284) . | No vascular complications (n = 1,877) . | P-Value . | Vascular complications (n = 270) . | No vascular complications (n = 727) . | P-Value . | |
| Operative time (min), median (IQR) | 68.0 (45.0; 86.2) | 48.0 (45.0; 60.0) | <0.001 | 63.5 (45.0; 80.0) | 50.0 (45.0; 60.0) | <0.001 |
| Need for vascular surgery, n (%) | 30 (10.7) | 0 (0.00) | <0.001 | 26 (9.74) | 0 (0.00) | <0.001 |
| Conversion to sternotomy, n (%) | 4 (1.41) | 6 (0.32) | 0.032 | 3 (1.11) | 2 (0.28) | 0.126 |
| Need for endovascular treatment,a n (%) | 230 (81.9) | 0 (0.00) | <0.001 | 224 (83.6) | 0 (0.00) | <0.001 |
| Number of implanted stents, n (%) | <0.001 | <0.001 | ||||
| 1 | 195 (69.6) | 0 (0.00) | 189 (70.8) | 0 (0.00) | ||
| 2 | 25 (8.93) | 0 (0.00) | 25 (9.36) | 0 (0.00) | ||
| 3 | 4 (1.43) | 0 (0.00) | 4 (1.50) | 0 (0.00) | ||
| 4 | 3 (1.07) | 0 (0.00) | 3 (1.12) | 0 (0.00) | ||
| Operative mortality, n (%) | 8 (2.82) | 9 (0.48) | 0.001 | 7 (2.59) | 5 (0.69) | 0.022 |
| In-hospital mortality, n (%) | 18 (6.34) | 39 (2.08) | <0.001 | 17 (6.30) | 23 (3.16) | 0.040 |
| Hospital length of stay (days), median (IQR) | 8.00 (6.00; 13.0) | 7.00 (5.00; 10.0) | <0.001 | 8.00 (5.75; 13.0) | 7.00 (5.00; 10.0) | 0.001 |
| Complications, n (%) | ||||||
| Conduction disorders, including pacemaker | 58 (20.4) | 432 (23.0) | 0.370 | 56 (20.7) | 151 (20.8) | 1.000 |
| Pacemaker implantation | 57 (20.1) | 376 (20.0) | 1.000 | 55 (20.4) | 130 (17.9) | 0.420 |
| ICD implantation | 0 (0.00) | 8 (0.43) | 0.607 | 0 (0.00) | 1 (0.14) | 1.000 |
| Valve-related complications | 2 (0.70) | 21 (1.12) | 0.759 | 2 (0.74) | 9 (1.24) | 0.737 |
| Stroke | 9 (3.17) | 31 (1.65) | 0.126 | 8 (2.96) | 14 (1.93) | 0.454 |
| Blood transfusion | 63 (22.2) | 59 (3.14) | <0.001 | 55 (20.4) | 31 (4.26) | <0.001 |
| Infectious complications | 26 (9.15) | 58 (3.09) | <0.001 | 24 (8.89) | 28 (3.85) | 0.003 |
| Dialysis | 94 (37.0) | 473 (28.3) | 0.005 | 90 (37.5) | 199 (31.2) | 0.093 |
| . | Before matching . | After matching . | ||||
|---|---|---|---|---|---|---|
| Vascular complications (n = 284) . | No vascular complications (n = 1,877) . | P-Value . | Vascular complications (n = 270) . | No vascular complications (n = 727) . | P-Value . | |
| Operative time (min), median (IQR) | 68.0 (45.0; 86.2) | 48.0 (45.0; 60.0) | <0.001 | 63.5 (45.0; 80.0) | 50.0 (45.0; 60.0) | <0.001 |
| Need for vascular surgery, n (%) | 30 (10.7) | 0 (0.00) | <0.001 | 26 (9.74) | 0 (0.00) | <0.001 |
| Conversion to sternotomy, n (%) | 4 (1.41) | 6 (0.32) | 0.032 | 3 (1.11) | 2 (0.28) | 0.126 |
| Need for endovascular treatment,a n (%) | 230 (81.9) | 0 (0.00) | <0.001 | 224 (83.6) | 0 (0.00) | <0.001 |
| Number of implanted stents, n (%) | <0.001 | <0.001 | ||||
| 1 | 195 (69.6) | 0 (0.00) | 189 (70.8) | 0 (0.00) | ||
| 2 | 25 (8.93) | 0 (0.00) | 25 (9.36) | 0 (0.00) | ||
| 3 | 4 (1.43) | 0 (0.00) | 4 (1.50) | 0 (0.00) | ||
| 4 | 3 (1.07) | 0 (0.00) | 3 (1.12) | 0 (0.00) | ||
| Operative mortality, n (%) | 8 (2.82) | 9 (0.48) | 0.001 | 7 (2.59) | 5 (0.69) | 0.022 |
| In-hospital mortality, n (%) | 18 (6.34) | 39 (2.08) | <0.001 | 17 (6.30) | 23 (3.16) | 0.040 |
| Hospital length of stay (days), median (IQR) | 8.00 (6.00; 13.0) | 7.00 (5.00; 10.0) | <0.001 | 8.00 (5.75; 13.0) | 7.00 (5.00; 10.0) | 0.001 |
| Complications, n (%) | ||||||
| Conduction disorders, including pacemaker | 58 (20.4) | 432 (23.0) | 0.370 | 56 (20.7) | 151 (20.8) | 1.000 |
| Pacemaker implantation | 57 (20.1) | 376 (20.0) | 1.000 | 55 (20.4) | 130 (17.9) | 0.420 |
| ICD implantation | 0 (0.00) | 8 (0.43) | 0.607 | 0 (0.00) | 1 (0.14) | 1.000 |
| Valve-related complications | 2 (0.70) | 21 (1.12) | 0.759 | 2 (0.74) | 9 (1.24) | 0.737 |
| Stroke | 9 (3.17) | 31 (1.65) | 0.126 | 8 (2.96) | 14 (1.93) | 0.454 |
| Blood transfusion | 63 (22.2) | 59 (3.14) | <0.001 | 55 (20.4) | 31 (4.26) | <0.001 |
| Infectious complications | 26 (9.15) | 58 (3.09) | <0.001 | 24 (8.89) | 28 (3.85) | 0.003 |
| Dialysis | 94 (37.0) | 473 (28.3) | 0.005 | 90 (37.5) | 199 (31.2) | 0.093 |
Infectious complications include septic shock, local access site infections and pulmonary infections.
Stent implantation/balloon dilatation/Fogarty.
ICD: implantable cardioverter–defibrillator; IQR: interquartile range.
This PDF is available to Subscribers Only
View Article Abstract & Purchase OptionsFor full access to this pdf, sign in to an existing account, or purchase an annual subscription.
